MindMaze Therapeutics Holding SA (MMTZF) Income Statement
MindMaze Therapeutics Holding SA Income Statement
Last quarter (Q2 2025), MindMaze Therapeutics Holding SA's total revenue was $1.22M, a decrease of 59.71% from the same quarter last year. In Q2, MindMaze Therapeutics Holding SA's net income was $-4.48M. See MindMaze Therapeutics Holding SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| $ 8.42M | $ 6.03M | $ 6.08M | $ 3.32M | $ 0.00 | |
| $ 5.84M | $ 4.11M | $ 4.83M | $ -8.59M | $ 0.00 | |
| $ 24.73M | $ 114.94M | $ 56.87M | $ 36.88M | $ 19.30M | |
| Depreciation and Amortization | $ 2.56M | $ 3.32M | $ 3.86M | $ 2.04M | $ 1.00K |
| $ -16.73M | $ -108.04M | $ -50.26M | $ -32.69M | $ -6.09M | |
| $ -18.89M | $ -110.83M | $ -52.04M | $ -34.31M | $ -19.30M | |
| $ -471.00K | $ -856.00K | $ -2.28M | $ -1.22M | $ 13.04M | |
| $ -19.36M | $ -111.68M | $ -54.32M | $ -35.52M | $ -6.26M | |
| $ -17.12M | $ -98.18M | $ -50.79M | $ -34.70M | $ -7.83M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.36 | $ -8.35 | $ -4.80 | $ -3.86 | $ -1.30 |
| Diluted EPS | $ -1.36 | $ -8.35 | $ -4.80 | $ -3.86 | $ -1.30 |
| Weighted Average Shares Outstanding | 12.54M | 11.75M | 10.57M | 8.98M | 6.03M |
| Weighted Average Shares Outstanding (Diluted) | 12.54M | 11.75M | 10.57M | 8.98M | 6.03M |
Currency in CHF
